Knowledge, attitudes, beliefs, and barriers associated with the uptake of influenza vaccine among pregnant women  by Mayet, Ahmed Y. et al.
Saudi Pharmaceutical Journal (2016) xxx, xxx–xxxKing Saud University
Saudi Pharmaceutical Journal
www.ksu.edu.sa
www.sciencedirect.comORIGINAL ARTICLEKnowledge, attitudes, beliefs, and barriers
associated with the uptake of influenza vaccine
among pregnant women* Corresponding author.
E-mail addresses: iymayet@ksu.edu.sa (A.Y. Mayet), drgalshaikh@gmail.com (G.K. Al-Shaikh), halmandeel@ksu.edu.sa (H.M. Al-M
ph.nada@yahoo.com (N.A. Alsaleh), ammouneh666@yahoo.com (A.F. Hamad).
Peer review under responsibility of King Saud University.
Production and hosting by Elsevier
http://dx.doi.org/10.1016/j.jsps.2015.12.001
1319-0164  2016 Production and hosting by Elsevier B.V. on behalf of King Saud University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Please cite this article in press as: Mayet, A.Y. et al., Knowledge, attitudes, beliefs, and barriers associated with the uptake of influenza vaccine among p
women. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/10.1016/j.jsps.2015.12.001Ahmed Y. Mayet a,*, Ghadeer K. Al-Shaikh b, Hazem M. Al-Mandeel b,
Nada A. Alsaleh c, Amani F. Hamad daCollege of Pharmacy, Clinical Pharmacy Department, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
bDepartment of Obstetrics and Gynecology, College of Medicine and King Khalid University Hospital, King Saud University,
Riyadh, Saudi Arabia
cCollege of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia
dPharmacy Department, King Khalid University Hospital, King Saud University, Riyadh, Saudi ArabiaReceived 7 September 2015; accepted 31 December 2015KEYWORDS
Knowledge of ﬂu vaccine;
Uptake of ﬂu vaccine;
Against ﬂu vaccine;
Flu vaccine and pregnancyAbstract Objective: The purpose of the study was to assess the knowledge, attitudes, beliefs, and
factors associated with the uptake of the inﬂuenza (ﬂu) vaccination in women within Saudi Arabia
during their pregnancy period. Methods: A cross-sectional prospective survey was conducted on
1085 pregnant women at the antenatal clinic over a period of 6 weeks with the provision of inﬂuenza
vaccination. The questionnaire collected demographic and other data; it included 12 questions on
their general knowledge and assessed their attitude toward inﬂuenza vaccination, and their aware-
ness of vaccine risk and the potential beneﬁts during pregnancy. The knowledge score obtained was
then calculated and compared. Results: A total of 998 patients took part in the questionnaire with a
response rate of 92%. There was poor awareness that the ﬂu vaccine is safe to administer during
pregnancy (130, 13.1%) and that all pregnant women should receive the ﬂu vaccine (190,
19.1%). Pregnant women with ﬂu vaccine knowledge score of 65 (range 0–12) were signiﬁcantly
less likely to take the vaccine (OR 3.78, 95% CI 2.68–5.26, p< 0.001). There was a low uptake
of the vaccine (178, 18.1%) and only 29 (3.0%) had previously been offered the ﬂu vaccine by
any doctor during their pregnancy. In addition, 255 (25.8%) were against taking the ﬂu vaccine
during pregnancy. Conclusion: The knowledge and uptake of the inﬂuenza vaccine among
Saudi pregnant women are low. One quarter was against the vaccine during pregnancy. Very fewandeel),
regnant
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women. Saudi Pharmaceutical Journal (2016believed the ﬂu vaccine to be safe during pregnancy. Rarely, physicians advise their clients to take
ﬂu vaccine.
 2016 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The inﬂuenza infection in pregnant women has been linked to
an increased risk of serious illnesses, longer hospitalization peri-
ods, an increase in premature delivery, and a higher mortality
rate (Anzic Inﬂuenza Investigators and Australasian
Maternity Outcomes Surveillance System, 2010; Jamieson
et al., 2009). Hospital admissions and respiratory illnesses
among pregnant women during the inﬂuenza season are much
higher compared to before their pregnancies (Cox et al., 2006;
Dodds et al., 2007). The inﬂuenza infection not only carries
the increased risk of serious illnesses for pregnant women, but
can also cause an increase in morbidity and mortality in infants
that are less than 6 months old (Bhat et al., 2005; Poehling et al.,
2006). Inﬂuenza vaccination can reduce the risk of respiratory
illnesses in pregnant women as well as in their newborn infants
up to age of 6 months (Zaman et al., 2008). A double-blind, ran-
domized placebo-controlled trial in Bangladesh showed that
new-born infants of mothers who were immunized with the
Inactivated Inﬂuenza Vaccine (IIV) during their third trimester
had fewer respiratory illnesses with fever, fewer clinic visits for
respiratory illness with fever, and fewer cases of laboratory-
conﬁrmed inﬂuenza during the ﬁrst 6 months of their life than
the control group. In the same study, vaccinated mothers also
had a 36% reduction in respiratory illnesses with fever, as com-
pared to women in the control group (Zaman et al., 2008).
Moreover, several observational studies have demonstrated
that newborns are protected from inﬂuenza illness when their
mothers have been vaccinated during or just prior to pregnancy.
Such protection from inﬂuenza illness among newborns is
almost certainly due to passive acquisition of antibodies to new-
borns frommaternal circulation via transplacental transmission
(Poehling et al., 2011; Steinhoff et al., 2010).
Although the inﬂuenza vaccine is safe and effective to
administer during pregnancy, the uptake of the ﬂu vaccine
among pregnant women varies. A systematic review of 21 stud-
ies assessed the coverage of the seasonal ﬂu vaccination, which
showed the uptake ranging between 1.7% and 88.4% (Yuen
and Tarrant, 2014). The rate of vaccine uptake increases if
women believe that they are at a higher risk of inﬂuenza-
related complications while pregnant (Yuet Sheung Yuen
et al., 2013a). Lack of awareness about the beneﬁts of the inﬂu-
enza vaccine is an obstacle to vaccine receipt (Beigi et al., 2009;
Yudin et al., 2009).
The Centers for Disease Control and Prevention’s Advisory
Committee on Immunization Practices (ACIP) and the Amer-
ican College of Obstetricians and Gynecologists recommend
that all women who are or will be pregnant during the inﬂu-
enza season have an IIV as soon as possible. All current avail-
able data overwhelmingly support the safety of the inﬂuenza
vaccination during pregnancy (Bednarczyk et al., 2012).
The researchers’ aims were to determine the knowledge,
attitudes, and beliefs toward the ﬂu vaccine, and the barriers
associated with the uptake in pregnant women in Saudi Arabia.Y. et al., Knowledge, attitudes, beliefs
), http://dx.doi.org/10.1016/j.jsps.2015.1during pregnancy. Currently, no such data are available within
the Kingdom. This study should help the authors to identify
opportunities for strategic initiatives to improve uptake of
ﬂu vaccine locally.
2. Materials and methods
This cross-sectional study was conducted in the outpatient
antenatal clinic at King Khalid University hospital in Riyadh,
Saudi Arabia, from July to August 2013. All pregnant women
above the age of 16 years, who were attending the outpatient
clinic for antenatal care follow-up treatment, were asked to
participate in the study during a regular clinic visit. Prior to
conducting the study, approval from the Institutional Review
Board (IRB) was obtained. The study objective was explained
prior to interview, and written consent was obtained if the
patient verbally agreed to participate. The questionnaire was
administered face-to-face by trained researchers, who were
monitored to ensure quality of research.
The questionnaire compromised of two parts. The ﬁrst part
collected the patient demographic data including age, their
educational level, occupation, income, and the number of preg-
nancies. The second part of the questionnaire measured general
knowledge of the ﬂu vaccine during pregnancy, attitude toward
inﬂuenza vaccination, and awareness of vaccine risk and the
potential beneﬁts during pregnancy. Some questions from the
previously validated survey by Yudin et al. were included with
modiﬁcations (Yudin et al., 2009). The survey was administered
in the Arabic language. It was tested on 50 patients who were
currently attending the antenatal clinic for the clarity, content
validity, internal consistency, and the ease of administration.
The sample size was calculated assuming 5% vaccine uptake,
at 95% level of conﬁdence, and with a precision of ±1.5%,
812 study subjects were required for the study. Assuming
15% non-responses, 934 patients were required for the study.
The questionnaire consisted of 12 knowledge questions with
the possibility of yes/no answers. Each correct answer was
given one point with total of 12 points for all correct answers.
A score above the median was considered as good knowledge
and a score at or below the median was considered as poor
knowledge of ﬂu vaccine. Descriptive statistics (means,
standard deviation, median, range, counts and percentages)
were used to describe the quantitative and categorical study
variables. A binary logistic regression model was used;
variables included in the model were education level
(high = undergraduates + post graduate, low = all others),
age group (<mean age, >mean age), employment status
(employed, unemployed), pregnancy (1, >1), and income level
(<mean income, >mean income in Saudi Riyals). Pearson’s
Chi-square tests and Fisher’s exact test were used to detect
whether there were any associations between demographic
characteristics, knowledge and attitude. Univariate odds ratios
(OR) were calculated between the categorical study and the
outcome variables were calculated to measure the strength of, and barriers associated with the uptake of influenza vaccine among pregnant
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Table 1 Demographic characteristics of pregnant women
participating in the survey.
Characteristics N= 998
Age (years)
<20 (%) 41 (4.1)
20–29 (%) 570 (57.1)
>30 (%) 387 (38.8)
Mean age (±SD) 28.4 (6.1)
Educational level (%)
Illiterate 14 (1.4)
Middle school/high school 342 (34.3)
Bachelor degree 540 (54.1)
Postgraduate studies 102 (10.2)
Employment status (%)
Yes 342 (34.3)
No 647 (64.8)
Missing data 9 (0.9)
Monthly income (Saudi Riyals)
<4000 (%) 106 (10.6)
4000–7000 (%) 364 (36.5)
7001–10,000 (%) 321 (32.2)
>10,000 (%) 190 (19.0)
Missing data (%) 17 (1.7)
Mean income in SR (±SD) 7039 (1753)
Number of pregnancies (%)
1 402 (40.3)
>1 580 (58.1)
Missing data 16 (1.6)
SR = Saudi Riyal.
Table 2 Percentage of pregnant women who responded to question
Items
Knowledge questions
Flu infection is highly contagious (n= 994)
Flu infection can sometimes be serious enough that a person needs to be
Pregnant women have same risk of complications from the ﬂu as women
Immunity decreases during pregnancy (n= 996)
The ﬂu vaccine is safe in pregnancy (n= 994)
Flu vaccine is safe in lactation (n= 993)
Flu vaccine can cause birth defects (n= 997)
Flu vaccine could cause inﬂuenza (n= 995)
Flu vaccine is expensive (n= 993)
Inﬂuenza vaccine is given in winter (n= 972)
Annual vaccination is the best way to protect from inﬂuenza (n= 995)
All pregnant women should get ﬂu vaccine (n= 995)
Uptake of ﬂu vaccine
Did you take ﬂu vaccine during pregnancy? (n= 986)
Attitude toward ﬂu vaccine
Are you against taking ﬂu vaccine during pregnancy? (n= 988)
Flu vaccine oﬀered by physician
Have you ever been oﬀered ﬂu vaccine by any doctor in your pregnancy
Flu = inﬂuenza, ﬂu vaccine is offered free to all pregnant women at our
a Correct answers of knowledge questions.
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used to ﬁnd out the independent associated variables among
the demographic background relating to knowledge and atti-
tude. A p value of <0.05 and 95% conﬁdence intervals of
ORs was used to report the statistical signiﬁcance and precision
of the estimates. Statistical analyses were conducted using the
Statistical Package for Social Science (SPSS) software (SPSS
Inc., Chicago, IL), version 18.0.
3. Results
A total of 1085 pregnant women were invited to participate in
the survey. Of those invited, 998 took part giving a response
rate of 92%. The mean age of the pregnant women in the study
was 28.4 ± 6.1 years and their mean income was 7039 ± 1753
SR. The demographic and other characteristics of the pregnant
women are presented in Table 1.
Knowledge scores are presented in Table 2. Most (908,
91.3%) of the pregnant women surveyed correctly stated that
inﬂuenza infection is highly contagious, although 459 (46.0%)
were unaware that pregnant women are at a higher risk of ﬂu
complications than non-pregnant women are. There was poor
awareness that the ﬂu vaccine is safe to administer during
pregnancy (130, 13.1%) and lactation (159, 16.0%), and that
all pregnant women should get ﬂu vaccine (190, 19.1%).
The median knowledge score of ﬂu vaccine among pregnant
women in the survey was 5 (range 0–12); 638 (63.9%) partici-
pants had poor knowledge of ﬂu vaccine (score 65) and 360
(36.1%) had good knowledge (>5). The distribution of knowl-
edge scores is shown in Fig. 1. Cronbach’s alpha coefﬁcient for
the 12-item scale was 0.642.s on knowledge, attitude, and uptake of inﬂuenza vaccine.
Patients response
Yes No
908 (91.3)a 86 (8.7)
admitted to the hospital (n= 969) 739 (76.2)a 230 (23.8)
who are not pregnant (n= 997) 459 (46.0) 538 (54.0)a
669 (67.2)a 327 (32.8)
130 (13.1)a 864 (86.1)
159 (16.0)a 834 (84.0)
161 (16.1) 836 (83.9)a
325 (32.7) 670 (67.3)a
373 (37.6) 620 (62.4)a
379 (40.1)a 593 (59.9)
531 (51.3)a 464 (46.7)
190 (19.1)a 805 (80.9)
178 (18.1) 808 (81.9)
255 (25.8) 733 (74.2)
? (n= 983) 29 (3.0) 954 (97.0)
hospital.
and barriers associated with the uptake of influenza vaccine among pregnant
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Figure 1 The distribution of knowledge scores of 998 pregnant
women who took part in survey.
4 A.Y. Mayet et al.To identify potential associations between poor knowledge
of the ﬂu vaccine (knowledge scores 65) and socio-
demographic characteristics, univariate and multivariate logis-
tic regression analyses were conducted. In univariate analyses,
pregnant women with below mean age (p< 0.004), who were
unemployed (p< 0.001), had below mean income (p< 0.001),
and who were in their ﬁrst pregnancy (p< 0.001) were signif-
icantly associated with poor ﬂu vaccine knowledge (Table 3).
In multivariate analyses, pregnant women with unemployed
status (OR 1.95, 95% CI 1.43–2.66, p 6 0.001), below mean
income (OR 1.57, 95% CI 1.16–2.11, p 6 0.003) and ﬁrst
pregnancy (OR 1.44, 95% CI 1.07–1.94, p 6 0.02) were still
signiﬁcantly associated with poor ﬂu vaccine knowledge afterTable 3 Association between socio-demographic variables and poo
Unadjusted odds ratio (95% CI)
Age groups (years)
Below mean age 1.55 (1.16, 2.07)
Above mean age 1
Employment status
Unemployed 2.21 (1.68, 2.89)
Employed 1
Income (in SR)
Below mean income 1.88 (1.44, 2.46)
Above mean age 1
Educational level
Low 1.25 (0.95, 1.65)
High 1
No. of pregnancies
1 1.73 (1.32, 2.27)
>1 1
Education level: high = post graduate + undergraduate, low = all others
CI) adjusted for all variables in the table: mean age, employed, mean inc
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level) (Table 3).
Overall, 178 (18.1%) pregnant women took the ﬂu vaccine
during pregnancy (Table 2). Pregnant women with poor
knowledge of the ﬂu vaccine were signiﬁcantly less likely to
take the ﬂu vaccine than those with good knowledge (OR
3.78, CI 2.68–5.26, p< 0.001). Poor uptake of the ﬂu vaccine
was also signiﬁcantly associated with pregnant women below
mean age (OR 1.54, 95% CI 1.05–2.25, p< 0.025), below
mean income (OR 1.90, 95% CI 1.35–2.66, p< 0.001), and
unemployed status (OR 2.77, 95% CI 1.98–3.87, p< 0.001),
and pregnant women with low education status (OR 2.29,
95% CI 1.55–3.36, p< 0.001) (Table 4). The multivariate
analyses showed that poor uptake of ﬂu vaccine is only inde-
pendently associated with unemployed status (OR 2.40, 95%
CI 1.63–3.53, p 6 0.001) after adjusting for the other depen-
dent variables (age, income, employment status, and education
level, number of pregnancies) (Table 4). Only 29 (3.0%) of all
participants were ever offered the ﬂu vaccine by any doctors
during their pregnancy.
One quarter (255, 25.8%) of the pregnant women who par-
ticipated in the survey were against taking the ﬂu vaccination
during pregnancy (Table 2). Pregnant women with low educa-
tion status (OR 1.66, 95% CI 1.24–2.22, p< 0.032) and in
their ﬁrst pregnancy (OR 1.51, 95% CI 1.12–2.03, p< 0.007)
were more likely to be against the ﬂu vaccine than those with
high education status or more than one pregnancy, respectively
(Table 4). Logistic regression analysis showed an independent
association between women who were against the inﬂuenza
vaccination in pregnancy and a low education status (OR
1.56, 95% CI 1.11–2.22, p 6 0.01), and women in their ﬁrst
pregnancy (OR 1.51, 95% CI 1.08–2.11, p 6 0.015) after
adjusting for other dependent variables (age, income, employ-
ment status) (Table 4). The pregnant women who did not take
the ﬂu vaccine during pregnancy were more likely to be against
it during pregnancy than those who were not against the vac-
cine (OR 2.52, 95% CI 1.60–3.98 p< 0.001). The participants
were then asked, if they were to take the ﬂu vaccine (even thoser knowledge of vaccine (score 65) in pregnant women.
p value Adjusted odds ratio (95% CI) p value
0.004 0.98 (0.70, 1.39) 0.939
1
0.001 1.95 (1.43, 2.66) 0.001
1
0.001 1.57 (1.16, 2.11) 0.003
1
0.110 0.86 (0.62, 1.19) 0.853
1
0.001 1.44 (1.07, 1.94) 0.018
1
, mean age = 28.4 years, mean income = 7,039 SR. Odd ratios (95%
ome, education level, and number of pregnancies.
, and barriers associated with the uptake of influenza vaccine among pregnant
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Table 4 Association between socio-demographic variables and uptake of ﬂu vaccine, and against ﬂu vaccine in pregnant women.
Unadjusted odds ratio (95% CI) Adjusted odds ratio (95% CI)
Vaccine uptake (n= 178) Against vaccine (n= 255) Vaccine uptake (n= 178) Against vaccine (n= 255)
Age groups (years)
Below mean age 1.54 (1.05, 2.25)* 1.17 (0.86, 1.61) 1.07 (0.68, 1.67) 0.92 (0.64, 1.32)
Above mean age 1 1 1 1
Employment status
Unemployed 2.77 (1.98, 3.87)* 1.98 (0.76, 1.38) 2.40 (1.63,3.53)* 1.24 (0.87, 1.75)
Employed 1 1 1 1
Income (in SR)
Below mean income 1.90 (1.35, 2.66)* 0.75 (0.57, 1.07) 1.28 (0.87, 1.88) 1.32 (0.95, 1.82)
Above mean income 1 1 1 1
Educational level
Low 2.29 (1.55, 3.36)* 1.66 (1.24, 2.22)* 1.31 (0.84, 2.05) 1.56 (1.11, 2.22)*
High 1 1 1 1
No. of pregnancies
1 1.00 (0.72, 1.40) 1.51 (1.12, 2.03)* 0.86 (0.59, 1.25) 1.51 (1.08, 2.11)*
<1 1 1 1 1
Education level: high = post graduate + undergraduate, low = all others. Mean age = 28.4 years, mean income = 7039SR.
Odd ratios (95% CI) adjusted for all variables in the table: mean age, employed, mean income, education level, and number of pregnancies.
* p values are <0.05.
Uptake of inﬂuenza vaccine among pregnant women 5against it), where they would prefer for it to be administered.
The results showed that 23% would prefer to take the vaccine
at the doctor’s ofﬁce and 14% post-delivery in the hospital,
and the remaining participants (53%) did not wish to take it.4. Discussion
The WHO in 2012, through the Strategic Advisory Group of
Experts on Immunization recommended that all pregnant
women should be immunized against inﬂuenza infection
because they are the most important risk group for seasonal
inﬂuenza compared to all risk groups, and that they will most
likely beneﬁt from the vaccination (World Health
Organization, 2012, 2003). Three major ﬁndings in this study
did not correlate with the WHO recommendations. These
included a low uptake of the vaccine among pregnant women
(18.1%) and only a meager 3% of all pregnant women ever
being offered the ﬂu vaccine by their doctors during their preg-
nancy. The third ﬁnding was that 25.5% of them were against
taking the ﬂu vaccination during pregnancy.
The present study suggests low knowledge of inﬂuenza vac-
cination among pregnant women with median score of 5 from
a possible of 12 on the scale. Pregnant women with low knowl-
edge of the ﬂu vaccine were signiﬁcantly less likely to take the
ﬂu vaccine as opposed to those with good knowledge. In addi-
tion, the pregnant women with low educational status were sig-
niﬁcantly less likely to take ﬂu vaccine during pregnancy as
well as generally being against the vaccination during preg-
nancy. Half of the pregnant women who were surveyed did
not believe that they were at a higher risk of complication from
inﬂuenza, and most (86%) of them stated that ﬂu vaccine is
not safe to administer during pregnancy. Results also showed
that half of the participants did not believe that annual
vaccinations are the best way to protect oneself from inﬂuenza.Please cite this article in press as: Mayet, A.Y. et al., Knowledge, attitudes, beliefs,
women. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/10.1016/j.jsps.2015.1Similarly, previous studies have conﬁrmed that the lack of
awareness about the beneﬁts of the inﬂuenza vaccine is an
obstacle to vaccine receipt (Beigi et al., 2009; Yudin et al.,
2009). In this study, women who are in their ﬁrst pregnancy
and have a low education status are identiﬁed as being the
major group for having poor knowledge of the inﬂuence vac-
cination within the Saudi Arabian population.
Overall, 178 (18.1%) of the 998 pregnant women took the
ﬂu vaccine during pregnancy. From a study done in Hong
Kong, the uptake during the seasonal inﬂuenza vaccine period
among pregnant women was only 1.7% (Yuet Sheung Yuen
et al., 2013b). Another study from Australia showed that the
uptake of antenatal seasonal inﬂuenza vaccine increased from
30% in 2010 to 40% in 2011 after the implementation of an
educational program for maternity staff and pregnant women
(McCarthy et al., 2012). Similar results were observed in a
Canadian study, showing that the inﬂuenza vaccination uptake
increased from 19% in 2006 to 56% in 2007, after distributing
educational pamphlets on inﬂuenza in antenatal clinics
(Naleway et al., 2006; Yudin et al., 2010). In Saudi Arabia,
improvements in awareness of the ﬂu vaccine could be accom-
plished by providing individual counseling, posters, booklets,
pamphlets, information sheets, web tools and audio/visual
materials on the safety, efﬁcacy and potential beneﬁts of the
inﬂuenza vaccine. During patient counseling, healthcare
providers must emphasize one of the greatest vaccine beneﬁts,
which is that it can reduce the risk of respiratory illnesses and
hospital admissions for them as well as for their newborn
infants up to the age of 6 months. Educational materials on
the ﬂu vaccine should be made available to encourage them
to be vaccinated during their clinic visits. Audiovisual presen-
tations containing safety, efﬁcacy, and potential beneﬁts of the
inﬂuenza vaccine should be presented to them while they are
waiting at the antenatal clinic for their appointment. Further-
more, in depth qualitative description research should beand barriers associated with the uptake of influenza vaccine among pregnant
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6 A.Y. Mayet et al.conducted to understand why pregnant women within Saudi
Arabia are against taking the ﬂu vaccine during pregnancy
and why they are not advised to take it.
Only 3% of all pregnant women were ever offered the ﬂu
vaccine by any doctors during their pregnancy in our survey.
Most healthcare providers are hesitant to provide a strong
opinion or a recommendation to their patients on the ﬂu vac-
cine, often due to their own lack of conﬁdence in the safety of
the vaccine and their fear of the consequences of liability if
anything goes wrong. They prefer pregnant women to take
their own responsibility and decide for themselves (Marteau
et al., 2001). However, studies consistently show that when
the recommendation and availability of inﬂuenza vaccination
during pregnancy come directly from their antenatal care pro-
viders, the likelihood of vaccine acceptance and receipt is much
higher (Ahluwalia et al., 2010; Shavell et al., 2012). Even
women who have safety concerns about the vaccine still indi-
cate that they would accept it if the provider recommended
it (Wiley et al., 2013). Healthcare providers’ attitudes and
beliefs around inﬂuenza vaccination clearly inﬂuence vaccine
uptake; a study showed vaccination awareness campaigns
aimed at obstetricians, primary care physicians, and midwives
had yielded large increases in coverage rates (Lam et al., 2010).
Another viable tactic is to encourage antenatal care providers
to offer the inﬂuenza vaccination to their clients at the clinic.
The study sample size was adequate given that it was calcu-
lated on assumption with 5% of the vaccine uptakes, at 95%
level of conﬁdence. The survey response rate was excellent at
92%.
The study researchers are aware of the limitations of this
study, including the use of a closed ended questionnaire rather
than focus group interviews or an open ended questionnaire,
which would have given an in depth review about the partici-
pants’ opinions and knowledge. In addition, the study is lim-
ited to a single center.
In conclusion, overall, the knowledge and uptake of the
inﬂuenza vaccine among Saudi pregnant women are low.
One quarter of the participants were against the vaccine during
pregnancy. Very few believed the ﬂu vaccine to be safe during
pregnancy, which may be associated with poor knowledge.
Rarely, physicians advise their clients to take ﬂu vaccine. Edu-
cational material aimed at pregnant women and support for
the antenatal healthcare providers is needed to increase aware-
ness and recommendations made to increase the uptake of the
vaccine.
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